A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals

NCT02766816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1120

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Response to Oral Polio Vaccine

Interventions

BIOLOGICAL: Part 1 study - BBio bOPV
BIOLOGICAL: Part 2 study - BBio bOPV Lot 1
BIOLOGICAL: Part 2 study - BBio bOPV Lot 2
BIOLOGICAL: Part 2 study - BBio bOPV Lot 3
BIOLOGICAL: Part 2 study - Licensed bOPV
BIOLOGICAL: Part 1 study - Licensed bOPV

Sponsor

Bilthoven Biologicals

Collaborators

[object Object]